Atlas Trials

Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors

Clinical trial NCT03415659 · UNKNOWN

Trial details

NCT number
NCT03415659
Sponsor
Hubei Biological Medicine Industrial Technology Institute Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsHRDBRCA Mutation
Start date
2018-03-05
Primary completion
2021-03-30
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.